MOTS-C is a mitochondria-derived peptide that has captured significant attention in the research community since its identification in 2015. Unlike the vast majority of bioactive peptides, which are encoded in the nuclear genome, MOTS-C is encoded within the mitochondrial 12S rRNA gene — making it one of a rare class of mitochondrial open reading frame peptides (MOPs) now recognized as key regulators of cellular energy homeostasis. Its unique genomic origin and its capacity to translocate from mitochondria to the nucleus under metabolic stress have made it a compelling subject for preclinical metabolic biology research.
As interest in mitochondrial-derived peptides (MDPs) continues to grow alongside broader research into AMPK signaling, insulin sensitivity models, and cellular resilience, MOTS-C has emerged as one of the most-studied molecules at the intersection of mitochondrial biology and systemic metabolic regulation. This guide provides laboratory researchers with a detailed overview of MOTS-C’s molecular structure, proposed mechanisms of action, and key findings from preclinical study models published through 2026.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Thymosin Alpha-1 10MG
$70.00$52.50 with 1st order
Frequently Asked Questions
What is MOTS-C and where does it come from?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically in the 12S ribosomal RNA gene. It represents a novel class of bioactive signaling molecules called mitochondrial-derived peptides (MDPs), which are distinct from nuclear-encoded peptides in both their origin and their regulatory functions.
What signaling pathway is MOTS-C most associated with in research?
Preclinical studies have most consistently associated MOTS-C with activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy balance. Research models have explored how MOTS-C may influence AMPK phosphorylation and downstream metabolic gene expression through both cytoplasmic and nuclear mechanisms.
Can MOTS-C translocate to the cell nucleus?
Yes — preclinical research has demonstrated that MOTS-C can translocate from the mitochondria to the nucleus, particularly under conditions of metabolic stress. In the nucleus, it has been shown in cell-based studies to interact with nuclear transcription factor networks, including those involved in stress response pathways such as Nrf2.
What metabolic processes has MOTS-C been studied in?
Preclinical research has examined MOTS-C in the context of glucose metabolism, mitochondrial respiration, folate cycle regulation, insulin sensitivity models, skeletal muscle metabolism, and cellular aging processes. Studies have also explored its behavior under caloric restriction and exercise-mimicking conditions in animal models.
Is MOTS-C an exercise-responsive peptide?
Research suggests MOTS-C levels in animal models appear to increase in response to physical exercise. A 2019 study published in Cell Metabolism observed that MOTS-C is released by skeletal muscle during exercise and may act as a systemic hormone-like signaling molecule, participating in exercise-induced metabolic adaptation in preclinical models.
How does MOTS-C relate to aging research?
Studies have investigated MOTS-C in the context of mitochondrial decline associated with aging. Preclinical findings suggest that endogenous MOTS-C levels may decrease with age in certain models, and exogenous administration in animal studies has been explored for its potential to influence age-related metabolic phenotypes — though these remain early-stage preclinical observations.
Where can researchers source MOTS-C for laboratory study?
MOTS-C is available as a lyophilized research-grade peptide for in vitro and preclinical laboratory use. Researchers should source from suppliers providing verifiable purity documentation. SourcePeptides.co offers MOTS-C in lyophilized and nasal spray formats for research applications.
Molecular Structure & Genomic Origins of MOTS-C
MOTS-C consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR. Its molecular weight is approximately 2.17 kDa. What distinguishes it fundamentally from other bioactive peptides is its mitochondrial genomic origin — a characteristic shared only with a handful of other identified MDPs, including humanin and SHLP1-6. The gene encoding MOTS-C sits within the 12S rRNA locus of the mitochondrial genome, a region long considered non-coding until the identification of these small open reading frames.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Thymosin Alpha-1 10MG
$70.00$52.50 with 1st order
This origin has meaningful implications for research. Because mitochondrial DNA (mtDNA) is maternally inherited and lacks the repair mechanisms of nuclear DNA, MOTS-C variants studied across different populations may carry subtle sequence differences that researchers have begun correlating with metabolic phenotype variation in population-level analyses. The peptide’s capacity to function as a retrograde mitochondria-to-nucleus signaling molecule further positions it at a unique intersection of organellar communication biology.
Comparison with Other Mitochondrial-Derived Peptides
MOTS-C is frequently compared with humanin, the first MDP to be characterized. While humanin has been most extensively studied in neuroprotection and apoptosis contexts, MOTS-C research has concentrated more heavily on skeletal muscle metabolism and systemic energy regulation. Both peptides are believed to participate in retrograde communication from mitochondria to other cellular compartments, but their receptor interactions and downstream signaling cascades appear distinct based on current preclinical data.
Proposed Mechanisms of Action: AMPK Pathways and Beyond
The most well-characterized mechanism explored in MOTS-C preclinical research is its activation of the AMPK (AMP-activated protein kinase) pathway. AMPK functions as a cellular energy sensor — when the AMP:ATP ratio rises (signaling low cellular energy), AMPK is phosphorylated and activates catabolic processes to restore energy balance. A 2015 study by Lee et al. in Cell Metabolism first described how exogenous MOTS-C administration in mouse models activated AMPK in skeletal muscle and white adipose tissue, influencing glucose uptake pathways.
Folate Cycle Inhibition and the AICAR Connection
A particularly notable mechanistic finding from early MOTS-C research involves the folate cycle. Studies have proposed that MOTS-C may inhibit the folate cycle — specifically the enzyme MTHFR (methylenetetrahydrofolate reductase) — leading to an accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a naturally occurring AMPK activator. This proposed mechanism would represent an indirect route to AMPK activation that does not require direct receptor binding, distinguishing it from other AMPK-activating molecules. Preclinical models examining this pathway have reinforced interest in MOTS-C’s relationship with one-carbon metabolism.
Nuclear Translocation Under Stress
Research published since 2019 has expanded understanding of MOTS-C’s intracellular behavior. Under conditions of oxidative stress or metabolic challenge, MOTS-C has been observed in cell-based studies to translocate from the mitochondrial compartment to the nucleus. Once in the nucleus, it appears to interact with transcription factor networks — including Nrf2, a key regulator of antioxidant response gene expression — suggesting a role in coordinating transcriptional responses to cellular stress that extends beyond its original characterization as a metabolic peptide.
This nuclear behavior has also drawn comparisons to research on other mitochondria-to-nucleus signaling peptides and has been highlighted in discussions alongside CJC-1295 & Ipamorelin stack research, which similarly explores the downstream transcriptional consequences of peptide-driven signaling cascades in metabolic tissues.
Key Preclinical Study Findings (2015–2026)
Skeletal Muscle Metabolism Models
Skeletal muscle represents the primary tissue context studied in MOTS-C preclinical research. The 2015 Lee et al. paper demonstrated that MOTS-C administration in diet-induced obese mouse models influenced insulin sensitivity parameters in skeletal muscle and reduced lipid accumulation in liver tissue. These findings were notable for suggesting that a mitochondria-derived signal could coordinate systemic metabolic responses across multiple tissue types simultaneously.
Exercise Biology Research
A 2019 study by Lee and colleagues, published in Cell Metabolism, introduced a compelling new dimension to MOTS-C research: its characterization as an exercise-induced hormone-like signaling molecule. The study found that MOTS-C concentrations in mouse serum increased significantly during treadmill exercise, and that the peptide was produced by skeletal muscle during physical activity rather than exclusively by mitochondria in other tissues. This finding reframed MOTS-C as a potential “exercise signal” and opened new research directions into how physical activity-induced mitochondrial signals might coordinate systemic metabolic responses.
Aging and Longevity Models
Several preclinical studies have examined MOTS-C in the context of biological aging. Research in aged mouse models has suggested that endogenous MOTS-C levels decline with chronological age, mirroring the broader pattern of mitochondrial functional decline observed in aged tissues. Supplementation studies in aged mice have explored whether exogenous MOTS-C might restore aspects of younger metabolic phenotype — though these remain early-stage findings requiring further investigation before mechanistic conclusions can be drawn.
This aging-biology angle situates MOTS-C research alongside other longevity-relevant peptides. Researchers interested in mitochondrial biology may also find the KLOW peptide stack research overview useful for understanding how multi-peptide approaches to regenerative biology have been explored in preclinical models.
Inflammatory Biology Observations
More recent preclinical research (2021–2024) has begun exploring MOTS-C’s potential interactions with inflammatory signaling pathways. Cell-based studies have observed that MOTS-C may influence NF-κB pathway activity, a central regulator of inflammatory gene transcription. These findings are preliminary but have expanded the research scope of MOTS-C beyond purely metabolic contexts into broader inflammatory biology, prompting comparisons with other peptides studied in inflammatory models — such as BPC-157, which has been explored extensively in inflammatory and tissue biology preclinical models.
MOTS-C in the Broader Context of Metabolic Peptide Research
MOTS-C does not exist in isolation as a research target. Its study sits within a growing field of metabolic peptide research that has expanded considerably with the emergence of GLP receptor biology. Researchers studying mitochondrial metabolic signals like MOTS-C often work alongside or in parallel with teams investigating incretin biology — a field that has produced significant research output examining molecules such as GLP-1 and GLP-2 incretin peptides, which regulate metabolic homeostasis through distinct receptor-mediated mechanisms. While MOTS-C’s mechanism is mitochondria-centric and AMPK-mediated rather than receptor-dependent at the cell surface, both research areas share a fundamental interest in how peptide signals coordinate systemic energy balance.
Similarly, the growing literature on triple-receptor metabolic peptides — reviewed in research covering GLP-3 multi-receptor biology — reflects the broader appetite in the research community for understanding how peptide signals with multiple downstream targets may exert broader metabolic regulatory effects than single-pathway molecules.
Laboratory Considerations for MOTS-C Research
Storage and Reconstitution
As a short 16-amino acid peptide, MOTS-C in lyophilized form is generally considered stable when stored at -20°C or below, protected from moisture and light. Reconstitution for in vitro work is typically performed using sterile bacteriostatic water or appropriate buffer systems. Researchers should consult current literature for reconstitution parameters specific to their experimental models. Proper bacteriostatic water quality is critical for maintaining peptide integrity — a topic explored in detail in the bacteriostatic water quality guide for research available in the SourcePeptides research library.
In Vitro vs. In Vivo Research Models
MOTS-C has been studied in both cell-based (in vitro) and whole-organism (in vivo) preclinical models. In vitro studies have primarily used C2C12 myocytes (skeletal muscle cell lines) and 3T3-L1 adipocytes to interrogate AMPK activation and glucose uptake pathways. In vivo studies have predominantly used C57BL/6 mouse models under high-fat diet or aging protocols. Researchers designing new studies should account for MOTS-C’s relatively rapid degradation in serum when planning in vivo experimental timelines.
Available Research Formats
MOTS-C for laboratory research is available from SourcePeptides.co in formats suited to different experimental needs:
MOTS-C 10MG Nasal Spray — for preclinical research applications →
Researchers exploring related mitochondrial-metabolic pathways may also find the following research-grade materials relevant to their experimental programs:
GLP-1 (S) 10MG Nasal Spray — for incretin receptor biology research →
GLP-3 (R) 60MG — for multi-receptor metabolic signaling research →
Pfizer Hospira Bacteriostatic Water 30mL — for peptide reconstitution in research →
Where These Fit in Your Research Library
MOTS-C occupies a distinct position in the metabolic peptide research landscape — sitting at the intersection of mitochondrial biology, AMPK signaling, and systemic metabolic regulation. Researchers building a comprehensive metabolic biology program may wish to explore related compounds and stacks available from SourcePeptides.co:
- MOTS-C 10MG Nasal Spray — mitochondrial-derived peptide for metabolic signaling research
- GLP-2 (T) 10MG Nasal Spray — intestinal trophic peptide for gut biology research
- SLU-PP-332 5MG — ERR agonist for mitochondrial biogenesis pathway research
Explore the full SourcePeptides research catalog at sourcepeptides.co.
Final Takeaway: MOTS-C as a Mitochondrial Research Priority
MOTS-C represents one of the most scientifically distinctive peptides available for preclinical research — a molecule whose mitochondrial genomic origin, AMPK-activating mechanisms, nuclear translocation behavior, and exercise-responsive biology collectively make it a high-value subject for researchers working at the frontier of metabolic science. The preclinical findings published between 2015 and 2026 have consistently reinforced the hypothesis that mitochondria function not merely as energy-producing organelles, but as active signaling hubs capable of issuing peptide-encoded instructions to the rest of the cell and organism.
For laboratory scientists studying mitochondrial function, cellular energy homeostasis, skeletal muscle metabolism, or biological aging, MOTS-C offers a well-characterized yet still-evolving research target with substantial mechanistic depth. As the MDP field continues to expand and new mitochondrial open reading frames are identified, MOTS-C is likely to remain central to our understanding of how mitochondrial signals shape systemic biology.
Sources & Further Reading
- Lee C et al. — “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance” — Cell Metabolism (2015)
- Lee C et al. — “MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism” — Free Radical Biology and Medicine (2019)
- Reynolds JC et al. — “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis” — Nature Communications (2021)
- PubMed Search — MOTS-C peptide AMPK metabolism research literature
- PubMed Search — Mitochondrial-derived peptides: humanin and MOTS-C comparative research
